Hedge Fund - Vivo Capital
Sinovac Biotech Ltd (SVA)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q4 (2025-12-31) | $38,192,410 | 2.47% | 5,903,000 | $ |
| 2 | 2025 - Q3 (2025-09-30) | $38,192,410 | 3.07% | 5,903,000 | $ |
| 3 | 2025 - Q2 (2025-06-30) | $38,192,410 | 3.91% | 5,903,000 | $ |
| 4 | 2024 - Q4 (2024-12-31) | $0 | 0% | 0 | $6.47 |
| 5 | 2024 - Q3 (2024-09-30) | $76,346,000 | 6.31% | 11,800,000 | $6.47 |
| 6 | 2024 - Q2 (2024-06-30) | $76,346,000 | 7.05% | 11,800,000 | $6.47 |
| 7 | 2024 - Q1 (2024-03-31) | $76,346,000 | 5.99% | 11,800,000 | $6.47 |
| 8 | 2023 - Q4 (2023-12-31) | $0 | 0% | 0 | $6.47 |
| 9 | 2023 - Q3 (2023-09-30) | $38,173,000 | 4.18% | 5,900,000 | $6.47 |
| 10 | 2023 - Q2 (2023-06-30) | $615,369,410 | 42.47% | 5,900,000 | $6.47 |
| 11 | 2023 - Q1 (2023-03-31) | $615,369,410 | 42.7% | 5,900,000 | $6.47 |
| 12 | 2022 - Q4 (2022-12-31) | $38,173 | 4.39% | 5,900,000 | $6.47 |
| 13 | 2022 - Q3 (2022-09-30) | $38,173,000 | 4.21% | 5,900,000 | $6.47 |
| 14 | 2022 - Q2 (2022-06-30) | $38,173,000 | 3.83% | 5,900,000 | $6.47 |
| 15 | 2022 - Q1 (2022-03-31) | $38,173,000 | 2.62% | 5,900,000 | $6.47 |
| 16 | 2021 - Q4 (2021-12-31) | $38,173,000 | 2.3% | 5,900,000 | $6.47 |
| 17 | 2021 - Q3 (2021-09-30) | $38,173,000 | 1.71% | 5,900,000 | $6.47 |
| 18 | 2021 - Q2 (2021-06-30) | $38,173,000 | 1.65% | 5,900,000 | $6.47 |
| 19 | 2021 - Q1 (2021-03-31) | $38,173,000 | 1.34% | 5,900,000 | $6.47 |
| 20 | 2020 - Q4 (2020-12-31) | $38,173,000 | 1.7% | 5,900,000 | $6.47 |
| 21 | 2020 - Q3 (2020-09-30) | $38,173,000 | 2.2% | 5,900,000 | $6.47 |
| 22 | 2020 - Q2 (2020-06-30) | $38,173,000 | 2.73% | 5,900,000 | $6.47 |
| 23 | 2020 - Q1 (2020-03-31) | $38,173,000 | 3.45% | 5,900,000 | $6.47 |
| 24 | 2019 - Q3 (2019-09-30) | $0 | 0% | 0 | $6.47 |
| 25 | 2019 - Q2 (2019-06-30) | $38,173,000 | 3.57% | 5,900,000 | $6.47 |
| 26 | 2019 - Q1 (2019-03-31) | $38,173,000 | 3.8% | 5,900,000 | $6.53 |
| 27 | 2018 - Q4 (2018-12-31) | $40,946,000 | 5.22% | 5,900,000 | $7.30 |
| 28 | 2018 - Q3 (2018-09-30) | $44,958,000 | 4.53% | 5,900,000 | $7.22 |
The displayed share prices are average quarterly stock market prices.